Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...

Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine ...

Immunotherapy: Hope, Hurdles, and a Clever Disguise Immunotherapies stand as one of the most promising paths in modern cancer treatment. Their main goal? To help the body’s own immune system hunt down ...

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Think you know the signs of prostate cancer? Discover the subtle urinary changes many men ignore that could be a vital early ...

Anatomical factors and device integration require modified diagnostic workflows to manage complicated urinary tract ...

A second scan using prostate-specific membrane antigen positron emission tomography changed treatment plans for nearly half of patients with recurrent prostate cancer whose initial scan was negative, ...

Researchers have developed a fully human antibody that suppressed tumor growth and metastatic spread in preclinical models of ...

Ask Orange County Mayor Jerry Demings how he’s doing nowadays and he smiles and says, “I’m doing well.” Last month, his staff ...

A team of researchers has reported an important advance in the search for better treatments for advanced prostate cancer.

Federal health officials are quietly moving to overhaul the fine print on testosterone replacement therapy, a shift that ...

An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.